Showing results (191-200 of 331) with videos related to

Sort By:
Pageof 34
Alimentary Pharmacology & Therapeutics|June 2, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled AnalysisLaurie-Rose Dubé, Mark Sorin, Matthieu Allez, et al.
Journal of Crohn'S & Colitis|July 12, 2025
Mirikizumab impact on disease clearance in patients with moderately to severely active ulcerative colitis: analysis of a pre-specified LUCENT trial endpointJean-Frederic Colombel, Jianmin Wu, Taku Kobayashi, et al.
Digestion|September 9, 2019
Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory TherapyFrancisco Portela, Paula Ministro, João de Deus, et al.
United European Gastroenterology Journal|May 11, 2024
Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast studyFerdinando D'Amico, Fernando Gomollón, Giorgos Bamias, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2025
Goblet Cell Loss Linked to NOD2 and Secondary Resection in Crohn's Disease is Induced by Dysbiosis and Epithelial MyD88Serre-Yu Wong, Maria Manuela Estevinho, Thomas Heaney, et al.
Inflammatory Bowel Diseases|January 9, 2020
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel DiseasePedro Pinto-Lopes, Joana Afonso, Rui Pinto-Lopes, et al.
Clinical and Translational Gastroenterology|February 15, 2021
Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?Paula Ministro, Cláudia Camila Dias, Francisco Portela, et al.
Gut|June 17, 2026
Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumptionJie Chen, Yang Guo, Jia Hu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With EtrasimodFernando Magro, Laurent Peyrin-Biroulet, Bruce E Sands, et al.
World Journal of Gastroenterology|July 4, 2015
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 casesSusana Rodrigues, Susana Lopes, Fernando Magro, et al.
Pageof 34